Literature DB >> 27372044

Advanced research on the microRNA mechanism in heart failure.

Jianying Deng1, Qianjin Zhong2.   

Abstract

Heart failure is the end stage of most cardiac diseases and also an important cardiovascular disease. Ventricular remodeling, a complicated pathophysiological process involving multiple molecular pathways, is a crucial mechanism for the occurrence and development of heart failure. A microRNA (miRNA) is a highly conservative noncoding molecule containing 18-25 nucleotides. miRNA is different from other RNAs. It mainly serves as an endogenous gene-regulating factor, and is a member of the complex regulatory network. It induces gene repression of target transcripts by affecting mRNA at the post-transcriptional level Vasudevan et al. (2007) . This study aimed at determining the mechanism of miRNA action in heart failure.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Heart failure; Mechanism; MicroRNA

Mesh：

Substances：

Year:  2016        PMID： 27372044     DOI： 10.1016/j.ijcard.2016.06.185

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  13 in total

Review 1.  MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers.

Authors:  Fanyan Luo; Wei Liu; Haisong Bu
Journal:  Heart Fail Rev       Date:  2022-03-25       Impact factor: 4.654

Review 2.  microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.

Authors:  Claudio de Lucia; Klara Komici; Giulia Borghetti; Grazia Daniela Femminella; Leonardo Bencivenga; Alessandro Cannavo; Graziamaria Corbi; Nicola Ferrara; Steven R Houser; Walter J Koch; Giuseppe Rengo
Journal:  Front Med (Lausanne)       Date:  2017-06-12

3.  Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation.

Authors:  Michela Masè; Margherita Grasso; Laura Avogaro; Elvira D'Amato; Francesco Tessarolo; Angelo Graffigna; Michela Alessandra Denti; Flavia Ravelli
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

4.  Cardiac-peripheral transvenous gradients of microRNA expression in systolic heart failure patients.

Authors:  Inbar Ben-Zvi; Natalia Volinsky; Liza Grosman-Rimon; Izhak Haviv; Guy Rozen; Nizar Andria; Nofar Asulin; Nufar Margalit; Ibrahim Marai; Offer Amir
Journal:  ESC Heart Fail       Date:  2020-04-06

5.  Differential expression of microRNA in serum fractions and association of Argonaute 1 microRNAs with heart failure.

Authors:  Eti Meiri; Natalia Volinsky; Nir Dromi; Sharon Kredo-Russo; Hila Benjamin; Sarit Tabak; Hagai Marmor; Maria Motin; Danit Lebanony; Gila Lithwick-Yanai; Etti Kadosh; Carol Kreader; Liza Grosman-Rimon; Offer Amir
Journal:  J Cell Mol Med       Date:  2020-05-13       Impact factor: 5.310

6.  miR-494 Contributes to Estrogen Protection of Cardiomyocytes Against Oxidative Stress via Targeting (NF-κB) Repressing Factor.

Authors:  Zhi-Ping Tang; Wei Zhao; Jian-Kui Du; Xin Ni; Xiao-Yan Zhu; Jian-Qiang Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-14       Impact factor: 5.555

7.  Ghrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family.

Authors:  Xiaotong Wang; Chunyan Yang; Xueyan Liu; Ping Yang
Journal:  Med Sci Monit       Date:  2018-09-23

8.  Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats.

Authors:  Ying Liao; Kaihong Chen; Xingmo Dong; Weiguo Li; Ganyang Li; Guoyong Huang; Wei Song; Liling Chen; Yong Fang
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

Review 9.  Oxidative Stress-Responsive MicroRNAs in Heart Injury.

Authors:  Branislav Kura; Barbara Szeiffova Bacova; Barbora Kalocayova; Matus Sykora; Jan Slezak
Journal:  Int J Mol Sci       Date:  2020-01-05       Impact factor: 5.923

10.  Molecular miR-19a in Acute Myocardial Infarction: Novel Potential Indicators of Prognosis and Early Diagnosis.

Authors:  Fatemeh Mansouri; Mir Hosein Seyed Mohammadzad
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.